CALIX, INC
CALXOther · Large accelerated filer · SEC filings ↗ · Compare ⊕
View price & chart on Yahoo Finance ↗Financials
SEC XBRL · annual| FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | |
|---|---|---|---|---|---|---|
| Revenue | $1.00B | $831.5M | $1.04B | $867.8M | $679.4M | $541.2M |
| Operating income | $21.0M | −$43.0M | $25.6M | $52.6M | $73.9M | $36.8M |
| Net income | $17.9M | −$29.7M | $29.3M | $41.0M | $238.4M | $33.5M |
| Total assets | $1.06B | $939.3M | $941.9M | $884.8M | $742.0M | $427.4M |
| Total liabilities | $199.3M | $158.3M | $222.9M | $205.3M | $173.6M | $147.0M |
| Equity | $859.2M | $780.9M | $719.0M | $679.6M | $568.4M | $280.3M |
| EPS (diluted) | $0.26 | $-0.45 | $0.42 | $0.60 | $3.51 | $0.54 |
| Shares out. | 66.7M | 65.4M | 66.1M | 64.4M | 62.5M | 56.6M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2025- Operating margin
- 2.1%
- Net margin
- 1.8%
- Return on equity
- 2.1%
- Return on assets
- 1.7%
- Return on capital (ROCE)
- 2.3%
- Liabilities / assets
- 18.8%
- Debt / equity
- 0.23×
- Book value / share
- $12.88
- Revenue growth (YoY)
- 20.3%
- Net income growth (YoY)
- —
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2025- Altman Z″ (distress)
- 6.79safe
- Accruals / assets
- −11.1%clean
- Beneish M-Score
- -2.84normal
- Piotroski F-Score
- 6/9mixed
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast. What these scores mean →
Signs
● 6 good- Operating margin is positive
- Revenue is growing year-over-year
- Conservative leverage (liabilities < 50% of assets)
- Positive operating cash flow
- Clean earnings (low accruals)
- Altman Z″ in the safe zone
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
5%+ owners
SEC Schedule 13D / 13G · last 3 yrs- Alliancebernstein L.P.Passive (13G)May 18, 2026
- Vanguard Portfolio Management LlcPassive (13G)Apr 29, 2026
- Vanguard Group IncPassive (13G)Mar 26, 2026
- Blackrock, Inc.Passive (13G)Jul 18, 2025
Holders who disclosed a 5%+ stake. 13D signals intent to influence or control; 13G is a passive holding. Latest filing per holder — open it for the exact stake.
Insider transactions
SEC Form 4 · most recent| Insider | Date | Type | Shares | Price |
|---|---|---|---|---|
| Bowick Christopher JDirector | May 14, 2026 | Grant | 4,967 | $0.00 |
| Berry Michael JDirector | May 14, 2026 | Grant | 4,967 | $0.00 |
| Mukherjee RajatishDirector | May 14, 2026 | Grant | 4,967 | $0.00 |
| Oosterman WadeDirector | May 14, 2026 | Grant | 4,967 | $0.00 |
| Peters Kevin RobertDirector | Feb 1, 2022 | Gift | 126,028 | $0.00 |
| Crusco Kathleen MDirector | May 14, 2026 | Grant | 4,967 | $0.00 |
| Russo CarlDirector | May 14, 2026 | Grant | 4,967 | $0.00 |
| Makagon KiraDirector | May 14, 2026 | Grant | 4,967 | $0.00 |
| Russo CarlDirector | Apr 27, 2026 | Sell | 20,909 | $43.17 |
| Russo CarlDirector | Apr 8, 2026 | Gift | 40,000 | $0.00 |
| Russo CarlDirector | Feb 25, 2026 | Option exercise | 10,000 | $12.63 |
Headline trade per Form 4 (officers, directors, 10%+ owners). Buy/sell read from the filing's structured data — blank where a field isn't cleanly tagged.
Short interest
FINRA · bi-monthly| Settlement | Shares short | Days to cover | Δ vs prior |
|---|---|---|---|
| May 15, 2026 | 5.4M | 7.3 | -10.9% |
| Apr 30, 2026 | 6.1M | 3.9 | +0.7% |
| Apr 15, 2026 | 6.0M | 7.3 | +1.4% |
| Mar 31, 2026 | 5.9M | 6.3 | +10.9% |
| Mar 13, 2026 | 5.3M | 8.5 | +8.4% |
Shares sold short as reported to FINRA. Days-to-cover = short shares ÷ average daily volume — higher means more potential squeeze pressure.
Material events
SEC Form 8-K · most recent- Shareholder voteMay 15, 2026
- Results of operationsApr 21, 2026
- Other material eventApr 21, 2026
- Results of operationsJan 28, 2026
- Other material eventJan 28, 2026
- Director / officer change · Regulation FD disclosureNov 17, 2025
- Results of operationsOct 29, 2025
- Results of operationsJul 21, 2025
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗Event-driven situations (3)
Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.